PRO-DEX, INC. Proceeds from Sale of Available-for-sale Securities, Equity
PRO-DEX, INC. (PDEX) reported Proceeds from Sale of Available-for-sale Securities, Equity of $1.32 million for the 9-month period ending 2015-03-31, per its 10-Q filed 2015-05-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity · last filed 2015-05-14
- PRO-DEX, INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2015-03-31 was $1.01M.
| Period end | Proceeds from Sale of Available-for-sale Securities, Equity 3 month | Proceeds from Sale of Available-for-sale Securities, Equity 6 month | Proceeds from Sale of Available-for-sale Securities, Equity 9 month |
|---|---|---|---|
| 2015-03-31 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | $1.32M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $318.00K 10-Q · filed 2015-02-10 | ||
| 2014-03-31 | $88.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |